Although a role for PRKACG and PRKAR1B in breast cancer has not been described, PRKACG has been shown to act as a RUNX1‐mutation associated hub gene in acute myeloid leukaemia29 and single nucleotide polymorphisms of PRKAR1B are associated with inferior survival of advanced renal cell cancer patients.30 This evidence concerns the gene PRKACG and breast carcinoma.